GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Blue Jet Healthcare Ltd (BOM:544009) » Definitions » Debt-to-EBITDA

Blue Jet Healthcare (BOM:544009) Debt-to-EBITDA : 0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Blue Jet Healthcare Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Blue Jet Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Blue Jet Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Blue Jet Healthcare's annualized EBITDA for the quarter that ended in Dec. 2024 was ₹5,490 Mil. Blue Jet Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 was 0.00.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Blue Jet Healthcare's Debt-to-EBITDA or its related term are showing as below:

During the past 4 years, the highest Debt-to-EBITDA Ratio of Blue Jet Healthcare was 0.25. The lowest was 0.00. And the median was 0.04.

BOM:544009's Debt-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 1.46
* Ranked among companies with meaningful Debt-to-EBITDA only.

Blue Jet Healthcare Debt-to-EBITDA Historical Data

The historical data trend for Blue Jet Healthcare's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Blue Jet Healthcare Debt-to-EBITDA Chart

Blue Jet Healthcare Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Debt-to-EBITDA
0.25 0.07 0.01 0.01

Blue Jet Healthcare Quarterly Data
Mar21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 - - -

Competitive Comparison of Blue Jet Healthcare's Debt-to-EBITDA

For the Biotechnology subindustry, Blue Jet Healthcare's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Blue Jet Healthcare's Debt-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Blue Jet Healthcare's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Blue Jet Healthcare's Debt-to-EBITDA falls into.


;
;

Blue Jet Healthcare Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Blue Jet Healthcare's Debt-to-EBITDA for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(12.34 + 3.79) / 2483.45
=0.01

Blue Jet Healthcare's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2024 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0 + 0) / 5490.2
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Dec. 2024) EBITDA data.


Blue Jet Healthcare  (BOM:544009) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Blue Jet Healthcare Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Blue Jet Healthcare's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Blue Jet Healthcare Business Description

Traded in Other Exchanges
Address
701, 702, 7th Floor, Plot No. 1 & 2, Bhumiraj Costarica, Sector 18, Sanpada, Navi Mumbai, MH, IND, 400 705
Blue Jet Healthcare Ltd is engaged in manufacturing of Pharma Intermediate, APIs used in Pharmaceutical and Healthcare Products. The operations of the company are organized in three product categories which are contrast media intermediates, artificial sweeteners, pharma intermediates, and active pharmaceutical ingredients.

Blue Jet Healthcare Headlines

No Headlines